A review of human and analogue insulin trials☆
To access this article, please choose from the options below
☆ The author has received honoraria for lectures and meeting attendance from Novo Nordisk, Eli Lilly, Sanofi Aventis and Pfizer.
PII: S0168-8227(06)00486-4
doi:10.1016/j.diabres.2006.10.015
© 2006 Elsevier Ireland Ltd. All rights reserved.
